SAN DIEGO, CA / ACCESSWIRE / October 24, 2024 / Dalrada Financial Corporation (OTCQB:DFCO) ("Dalrada," "the Company"), announced today that it has engaged the PCAOB auditing firm, CM3 Advisory ("CM3"), as its independent registered public accounting firm. With years of experience and knowledge across numerous industries, CM3 is a perfect fit for Dalrada.
"CM3 understands our diverse operations and offers a unique level of service that will support our Company's growth for years to come," said Dalrada Chairman and CEO, Brian Bonar. "I look forward to working with them to ensure that our auditing process is as smooth as possible."
Along with PCAOB auditing services, CM3 provides expert assurance, advisory, and tax assistance across multiple sectors including manufacturing, technology, aerospace, and private equity. The firm's expertise spans mergers and acquisitions, exit planning, and various business services for both public and private companies.
CM3 is now engaged to audit Dalrada's consolidated financial statements for the 2024 fiscal year as well as subsequent quarters.
About Dalrada Financial Corporation
Dalrada Financial Corporation (OTCQB: DFCO) is a multi-national holding company that develops, manufactures, and sells a robust suite of products and services in the Clean Energy and Health Care sectors. Dalrada's core segments include Dalrada Climate Technology, which offers cutting-edge heat pump technology for industrial and residential applications, and Genefic Specialty Pharmacy, which provides end-to-end prescription services as well as patient advocacy and support.
Dalrada consistently drives innovation that delivers maximum impact, bringing increased value to its shareholders.
For more information, please visit www.dalrada.com, and follow us on LinkedIn, Facebook, Twitter, and YouTube.
About CM3 Advisory
Founded in 2020, CM3 Advisory is a PCAOB-approved financing advisory firm headquartered in San Diego, California. The group provides services for mergers and acquisitions transaction advisory and exit planning, pre-transaction prep and post-merger integration, consulting, assurance, and tax services. CM3 caters to the sectors of private equity funds and independent sponsors, manufacturing and distribution, aerospace and defense, food and beverage, technology and life sciences, business services, and employee benefit plans.
Forward-Looking Statements
Statements contained in this press release, other than statements of historical fact, particularly statements relating to cost reductions and the anticipated pre-tax savings from the cost reduction program, restructuring costs, footprint rationalization, simplifying and streamlining our operations, reducing complexity, enhancing the speed of decision-making, leveraging our sourcing capabilities and the timing of implementation and completion of the cost reduction program, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of management based on information available to us at the time such statements are made. These statements, which are generally identifiable by the use of the words "will," "believe," "expect," "intend," "anticipate," "estimate," "forecast," "project," "plan," and similar expressions, are subject to certain risks and uncertainties, are made as of the date hereof, and we undertake no duty or obligation to update them. Forward-looking statements are subject to the occurrence of many events outside the Company's control and actual results and the timing of events may differ materially from those suggested or implied by such forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the US Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.
Media contact: Michael Eslinger ([email protected])
# # #
SOURCE: Dalrada Financial Corp.